Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
Mol Biol Rep
; 49(2): 1259, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-34977990
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Risk_factors_studies
Language:
En
Journal:
Mol Biol Rep
Year:
2022
Document type:
Article
Affiliation country:
Túnez
Country of publication:
Países Bajos